1. Home
  2. RCKT vs GPRK Comparison

RCKT vs GPRK Comparison

Compare RCKT & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • GPRK
  • Stock Information
  • Founded
  • RCKT 1999
  • GPRK 2002
  • Country
  • RCKT United States
  • GPRK Colombia
  • Employees
  • RCKT N/A
  • GPRK N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • GPRK Oil & Gas Production
  • Sector
  • RCKT Health Care
  • GPRK Energy
  • Exchange
  • RCKT Nasdaq
  • GPRK Nasdaq
  • Market Cap
  • RCKT 328.6M
  • GPRK 335.7M
  • IPO Year
  • RCKT N/A
  • GPRK N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • GPRK $6.60
  • Analyst Decision
  • RCKT Buy
  • GPRK Buy
  • Analyst Count
  • RCKT 13
  • GPRK 1
  • Target Price
  • RCKT $12.96
  • GPRK $11.00
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • GPRK 689.9K
  • Earning Date
  • RCKT 08-07-2025
  • GPRK 08-05-2025
  • Dividend Yield
  • RCKT N/A
  • GPRK 8.91%
  • EPS Growth
  • RCKT N/A
  • GPRK N/A
  • EPS
  • RCKT N/A
  • GPRK 0.81
  • Revenue
  • RCKT N/A
  • GPRK $560,354,000.00
  • Revenue This Year
  • RCKT N/A
  • GPRK N/A
  • Revenue Next Year
  • RCKT $108.43
  • GPRK N/A
  • P/E Ratio
  • RCKT N/A
  • GPRK $8.19
  • Revenue Growth
  • RCKT N/A
  • GPRK N/A
  • 52 Week Low
  • RCKT $2.19
  • GPRK $5.66
  • 52 Week High
  • RCKT $22.01
  • GPRK $11.72
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • GPRK 50.84
  • Support Level
  • RCKT $2.88
  • GPRK $6.28
  • Resistance Level
  • RCKT $3.74
  • GPRK $6.67
  • Average True Range (ATR)
  • RCKT 0.27
  • GPRK 0.20
  • MACD
  • RCKT 0.02
  • GPRK 0.02
  • Stochastic Oscillator
  • RCKT 35.43
  • GPRK 63.01

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About GPRK Geopark Ltd

GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.

Share on Social Networks: